Systematic Analysis of the Associations between Adverse Drug Reactions and Pathways

Abstract EN

Adverse drug reactions (ADRs) are responsible for drug candidate failure during clinical trials.

It is crucial to investigate biological pathways contributing to ADRs.

Here, we applied a large-scale analysis to identify overrepresented ADR-pathway combinations through merging clinical phenotypic data, biological pathway data, and drug-target relations.

Evaluation was performed by scientific literature review and defining a pathway-based ADR-ADR similarity measure.

The results showed that our method is efficient for finding the associations between ADRs and pathways.

To more systematically understand the mechanisms of ADRs, we constructed an ADR-pathway network and an ADR-ADR network.

Through network analysis on biology and pharmacology, it was found that frequent ADRs were associated with more pathways than infrequent and rare ADRs.

Moreover, environmental information processing pathways contributed most to the observed ADRs.

Integrating the system organ class of ADRs, we found that most classes tended to interact with other classes instead of themselves.

ADR classes were distributed promiscuously in all the ADR cliques.

These results reflected that drug perturbation to a certain pathway can cause changes in multiple organs, rather than in one specific organ.

Our work not only provides a global view of the associations between ADRs and pathways, but also is helpful to understand the mechanisms of ADRs.